Barry Rosen
Overview
Explore the profile of Barry Rosen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
5204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu Y, Herzberg M, Pat-Espadas A, Vinuesa P, Feng R, Rosen B, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39795967
Microbes have been shown to adapt to stressful or even lethal conditions through displaying genome plasticity. However, how bacteria utilize the ability of genomic plasticity to deal with high antimony...
2.
Ochomo E, Tonui P, Muthoka K, Amboka S, Itsura P, Orango E, et al.
Ecancermedicalscience
. 2024 Oct;
18:1735.
PMID: 39421184
Introduction: Human papillomavirus (HPV) causes cervical cancer, and HPV vaccination is highly effective in preventing vaccine-targeted HPV infection. However, low HPV vaccination coverage in Kisumu County, Kenya, at about 10%...
3.
Whitworth P, Beitsch P, Patel R, Rosen B, Compagnoni G, Baron P, et al.
JAMA Netw Open
. 2022 Sep;
5(9):e2232787.
PMID: 36136330
Importance: National Comprehensive Cancer Network guidelines currently recommend germline testing for high-risk genes in selected patients with breast cancer. The clinical utility of recommending testing all patients with breast cancer...
4.
Kotsopoulos J, Zamani N, Rosen B, McLaughlin J, Risch H, Kim S, et al.
Br J Cancer
. 2022 Jun;
127(5):879-885.
PMID: 35710751
Background: Several clinical and tumour factors impact on ovarian cancer survival. It is important to evaluate if germline mutations impact long-term outcomes among patients with epithelial ovarian cancer. Methods: We...
5.
Arden J, Dokter J, Almahariq M, Marvin K, Nandalur S, Al-Wahab Z, et al.
Adv Radiat Oncol
. 2021 Dec;
6(6):100773.
PMID: 34934859
Purpose: This study aimed to evaluate outcomes and toxicity in patients with endometrial cancer per our institutional adjuvant vaginal cuff brachytherapy (VBT) fractionation scheme. Methods And Materials: We identified women...
6.
Finch A, Metcalfe K, Akbari M, Friedman E, Tung N, Rosen B, et al.
Clin Genet
. 2021 Dec;
101(3):317-323.
PMID: 34897671
Approximately 1% of the Ashkenazi Jewish population carries the BRCA2 6174delT (c.5946del) pathogenic variant. It is important to have accurate knowledge of the risks of breast and ovarian cancer associated...
7.
Gu S, Lheureux S, Sayad A, Cybulska P, Hogen L, Vyarvelska I, et al.
Proc Natl Acad Sci U S A
. 2021 Jun;
118(25).
PMID: 34161278
High-grade serous tubo-ovarian carcinoma (HGSC) is a major cause of cancer-related death. Treatment is not uniform, with some patients undergoing primary debulking surgery followed by chemotherapy (PDS) and others being...
8.
Birling M, Yoshiki A, Adams D, Ayabe S, Beaudet A, Bottomley J, et al.
Nat Genet
. 2021 Apr;
53(4):416-419.
PMID: 33833456
No abstract available.
9.
Zabulica M, Srinivasan R, Akcakaya P, Allegri G, Bestas B, Firth M, et al.
Mol Ther
. 2021 Jan;
29(5):1903-1917.
PMID: 33484963
Ornithine transcarbamylase deficiency (OTCD) is a monogenic disease of ammonia metabolism in hepatocytes. Severe disease is frequently treated by orthotopic liver transplantation. An attractive approach is the correction of a...
10.
Kim S, Kotsopoulos J, Sun P, Bernardini M, Laframboise S, Ferguson S, et al.
Int J Gynaecol Obstet
. 2020 Dec;
153(3):417-423.
PMID: 33326624
Objective: To compare the long-term survival outcomes for women with advanced ovarian cancer treated with chemotherapy either before or after surgery (neoadjuvant chemotherapy vs primary cytoreductive surgery) at a single...